Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PYGL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CMIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPATCH4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP2A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PWP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGB1BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01128 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ASTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH7A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLCO2A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIF1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCTA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NELFCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506538 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on